These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20501625)

  • 21. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.
    Swain SM; Lippman ME; Egan EF; Drake JC; Steinberg SM; Allegra CJ
    J Clin Oncol; 1989 Jul; 7(7):890-9. PubMed ID: 2661735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers.
    Noordhuis P; Holwerda U; Van der Wilt CL; Van Groeningen CJ; Smid K; Meijer S; Pinedo HM; Peters GJ
    Ann Oncol; 2004 Jul; 15(7):1025-32. PubMed ID: 15205195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma.
    Hofmeister CC; Jansak B; Denlinger N; Kraut EH; Benson DM; Farag SS
    Leuk Res; 2008 Aug; 32(8):1295-8. PubMed ID: 18082257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors.
    Grem JL; Kos ME; Evande RE; Meza JL; Schwarz JK
    Cancer; 2015 Nov; 121(21):3862-8. PubMed ID: 26242208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
    Bael TE; Peterson BL; Gollob JA
    Melanoma Res; 2008 Apr; 18(2):147-51. PubMed ID: 18337652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
    Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial.
    Leichman L; Lenz HJ; Leichman CG; Groshen S; Danenberg K; Baranda J; Spears CP; Boswell W; Silberman H; Ortega A
    Eur J Cancer; 1995; 31A(7-8):1306-10. PubMed ID: 7577041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.
    Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM
    J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic trioxide in patients with refractory multiple myeloma: a prospective, phase II, single-arm study.
    Sanaat Z; Rezazadeh M; Gharamaleki JV; Ziae JE; Esfahani A
    Acta Med Iran; 2011; 49(8):504-8. PubMed ID: 22009804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma.
    Zhao H; Sun G; Kong D; Zhang Y; Shi W; Zhao M; Hong L; Qiao Z
    Med Oncol; 2015 Mar; 32(3):79. PubMed ID: 25698531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients.
    Rousselot P; Larghero J; Arnulf B; Poupon J; Royer B; Tibi A; Madelaine-Chambrin I; Cimerman P; Chevret S; Hermine O; Dombret H; Claude Brouet J; Paul Fermand J
    Leukemia; 2004 Sep; 18(9):1518-21. PubMed ID: 15269785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL; Erlichman C
    Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination.
    Cascinu S; Catalano V; Aschele C; Barni S; Debernardis D; Gallo L; Bandelloni R; Staccioli MP; Baldelli AM; Brenna A; Valenti A; Muretto P; Catalano G
    Ann Oncol; 2000 Aug; 11(8):1053-6. PubMed ID: 11038045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a European multicentre trial of Tomudex versus 5-FU/high dose LV (Machover regimen).
    Cocconi G
    Tumori; 1997; 83(1 Suppl):S72. PubMed ID: 9154075
    [No Abstract]   [Full Text] [Related]  

  • 35. A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancer.
    Blanke CD; Mattek NC; Deloughery TG; Koop DR
    Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):169-72. PubMed ID: 15789623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma.
    Berenson JR; Swift RA; Ferretti D; Purner MB
    Clin Lymphoma; 2004 Sep; 5(2):130-4. PubMed ID: 15453931
    [No Abstract]   [Full Text] [Related]  

  • 37. [Application of arsenic trioxide in comprehensive therapy of liver carcinoma].
    Li JT; Ou QJ; Wu YC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Dec; 23(12):931-2. PubMed ID: 14714369
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old.
    Parmar S; Rundhaugen LM; Boehlke L; Riley M; Nabhan C; Raji A; Frater JL; Tallman MS
    Leuk Res; 2004 Sep; 28(9):909-19. PubMed ID: 15234567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolongation of cardiac repolarization by arsenic trioxide.
    Chiang CE; Luk HN; Wang TM; Ding PY
    Blood; 2002 Sep; 100(6):2249-52. PubMed ID: 12200393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of 5-fluorouracil/leucovorin chemotherapy on CpG methylation, or the confounding role of leukocyte heterogeneity: An illustration.
    Lemire M; Zaidi SH; Zanke BW; Gallinger S; Hudson TJ; Cleary SP
    Genomics; 2015 Dec; 106(6):340-7. PubMed ID: 26368860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.